Devyser Diagnostics AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	250.5	216.9	169.3	126.6	93.48
Revenue Growth (YoY)	15.49%	28.12%	33.73%	35.43%	42.31%
Cost of Revenue	48.6	44.2	24.5	23.2	21.57
Gross Profit	201.9	172.7	144.8	103.4	71.91
Selling, General & Admin	173.3	193.1	163.5	132.1	75.65
Research & Development	18	43.1	37.8	26.3	18.07
Other Operating Expenses	1.3	-0.9	-0.3	-0.2	-0.12
Operating Expenses	192.6	235.3	201	158.2	93.6
Operating Income	9.3	-62.6	-56.2	-54.8	-21.69
Interest Expense	-13.6	-3.5	-0.8	-0.5	-0.94
Interest & Investment Income	0.9	4.2	5	0.3	0.01
Earnings From Equity Investments	-	-	-	-	0.37
Currency Exchange Gain (Loss)	0.7	4.8	-2.3	1.2	0.06
Other Non Operating Income (Expenses)	0.1	-0.1	-	-	0.22
EBT Excluding Unusual Items	-2.6	-57.2	-54.3	-53.8	-21.97
Gain (Loss) on Sale of Investments	-	-	-	1.6	-
Gain (Loss) on Sale of Assets	-	-0.4	-0.4	0.1	0.07
Asset Writedown	-	-	0.3	-0.7	-0
Pretax Income	-2.6	-57.6	-54.4	-52.8	-21.91
Income Tax Expense	5.8	3.9	-0.8	-6.8	-1.18
Net Income	-8.4	-61.5	-53.6	-46	-20.73
Net Income to Common	-8.4	-61.5	-53.6	-46	-20.73
Shares Outstanding (Basic)	17	16	16	16	11
Shares Outstanding (Diluted)	17	16	16	16	11
Shares Change (YoY)	1.19%	1.34%	1.63%	41.78%	28.98%
EPS (Basic)	-0.51	-3.75	-3.31	-2.89	-1.85
EPS (Diluted)	-0.51	-3.75	-3.31	-2.89	-1.85
Free Cash Flow	6.7	-72.6	-81.2	-48.4	-18.68
Free Cash Flow Per Share	0.40	-4.43	-5.02	-3.04	-1.66
Gross Margin	80.60%	79.62%	85.53%	81.67%	76.93%
Operating Margin	3.71%	-28.86%	-33.20%	-43.29%	-23.20%
Profit Margin	-3.35%	-28.35%	-31.66%	-36.34%	-22.17%
Free Cash Flow Margin	2.67%	-33.47%	-47.96%	-38.23%	-19.98%
EBITDA	30.7	-56.1	-52.5	-52.6	-20.99
EBITDA Margin	12.26%	-25.86%	-31.01%	-41.55%	-22.46%
D&A For EBITDA	21.4	6.5	3.7	2.2	0.69
EBIT	9.3	-62.6	-56.2	-54.8	-21.69
EBIT Margin	3.71%	-28.86%	-33.20%	-43.29%	-23.20%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.